Ypeginterferon alfa-2b
TB1211IFN
Phase 3 small_molecule completed
Quick answer
Ypeginterferon alfa-2b for Chronic Hepatitis B is a Phase 3 program (small_molecule) at First Tracks Biotherapeutics with 3 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Chronic Hepatitis B
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed